Product information
From Health Canada
Current status:
Cancelled Post Market
Current status date:
2005-08-10
Original market date: See footnote 1
1996-09-18
Product name:
NOVO-RIDAZINE (THIORIDAZINE ORAL SUSPENSION) - 2 MG/ML
DIN:
02229553 Electronic product monograph is not available
Company:
NOVOPHARM LIMITED
30 Novopharm Court
Toronto
Ontario
Canada
M1B 2K9
Class:
Human
Dosage form(s):
Suspension
Route(s) of administration:
Oral
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
28:16.08.24
Anatomical Therapeutic Chemical (ATC): See footnote 4
N05AC02 THIORIDAZINE
Active ingredient group (AIG) number:See footnote5
0106198001
Active ingredient(s) | Strength |
---|---|
THIORIDAZINE | 2 MG / ML |